Rune Falkenberg Haller

Title: Innovations of Rune Falkenberg Haller

Introduction

Rune Falkenberg Haller is a notable inventor based in Roskilde, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and methods related to phospholipase C activity. With a total of 4 patents to his name, Haller's work has implications for various applications in the industry.

Latest Patents

Haller's latest patents focus on polypeptides having phospholipase C activity and the polynucleotides encoding them. His inventions relate to methods for reducing the phospholipid content in oil or fat compositions. The patents describe polypeptides with specific activities, including PI-specific and PC, PE-specific phospholipase C activities. Additionally, the inventions encompass polynucleotides encoding these polypeptides, along with nucleic acid constructs, vectors, and host cells that incorporate the polynucleotides. These innovations provide valuable methods for producing and utilizing the polypeptides effectively.

Career Highlights

Haller is currently associated with Novozymes A/S, a leading company in the field of biotechnology. His work at Novozymes has allowed him to further his research and development efforts in enzyme technology and related areas. His contributions have been instrumental in advancing the company's innovative solutions.

Collaborations

Haller has collaborated with several talented individuals in his field, including Dorotea Raventos Segura and Robert Piotr Olinski. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Rune Falkenberg Haller is a distinguished inventor whose work in biotechnology has led to significant advancements in enzyme technology. His patents reflect a commitment to innovation and practical applications in the industry. Haller's contributions continue to influence the field and inspire future research endeavors.